Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.

drugs erythema flushing lasers lifestyle management ocular papules phenotypes phymatous pustules rosacea telangiectasia therapy utility

Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 20 02 2019
revised: 24 10 2019
accepted: 31 01 2020
pubmed: 10 2 2020
medline: 22 1 2021
entrez: 10 2 2020
Statut: ppublish

Résumé

In 2017, a National Rosacea Society Expert Committee developed and published an updated classification of rosacea to reflect current insights into rosacea pathogenesis, pathophysiology, and management. These developments suggest that a multivariate disease process underlies the various clinical manifestations of the disorder. The new system is consequently based on phenotypes that link to this process, providing clear parameters for research and diagnosis as well as encouraging clinicians to assess and treat the disorder as it may occur in each individual. Meanwhile, a range of therapies has become available for rosacea, and their roles have been increasingly defined in clinical practice as the disorder has become more widely recognized. This update is intended to provide a comprehensive summary of management options, including expert evaluations, to serve as a guide for tailoring treatment and care on an individual basis to achieve optimal patient outcomes.

Identifiants

pubmed: 32035944
pii: S0190-9622(20)30166-3
doi: 10.1016/j.jaad.2020.01.077
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1501-1510

Informations de copyright

Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Diane Thiboutot (D)

Department of Dermatology, Pennsylvania State University, Hershey, Pennsylvania. Electronic address: dthiboutot@pennstatehealth.psu.edu.

Rox Anderson (R)

Department of Dermatology and Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Fran Cook-Bolden (F)

Skin of Color Center, Department of Dermatology, St Luke's-Roosevelt Hospital, New York, New York.

Zoe Draelos (Z)

Department of Dermatology, Duke University, Durham, North Carolina.

Richard L Gallo (RL)

Department of Dermatology, University of California-San Diego, San Diego, California.

Richard D Granstein (RD)

Department of Dermatology, Weill Cornell Medical College, New York, New York.

Sewon Kang (S)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland.

Marian Macsai (M)

Department of Ophthalmology, University of Chicago, Chicago, Illinois.

Linda Stein Gold (LS)

Department of Dermatology, Henry Ford Health System, West Bloomfield, Michigan.

Jerry Tan (J)

Department of Medicine, University of Western Ontario, Windsor, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH